Clinical Trial Update: Recurrence Rate, Risk Factors for the Recurrence, and Quality of Life in Patients With GERD in Korea-an Observational

View source ↗

Summary

This observational study conducted in Korea evaluated the recurrence rate of gastroesophageal reflux disease after proton pump inhibitor treatment, the factors …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: The Aim of This Study is to Investigate the Frequency and Related Risk Factors of Recurrence, and Quality of Life in Patients With GERD After Treatment With PPI | Status: COMPLETED